Agape ATP Corp. - Wutah pendapatan triwulanan ATPC

Agape ATP (ATPC) - logo korporat

Agape ATP Corporation (ATPC) is scaling its preventive medicine IT services and direct sales in Asia. The quarterly revenue growth rate confirms this momentum, with the current mark standing at -97.80. The development of medical tourism and demand for dietary supplements will strengthen the client portfolio, while outsourcing production to external vendors completely mitigates operational risks and logistics disruptions.

ATPC Tingkat wutah dodolan sajrone kuartal Agape ATP Corporation (21.02.2024 - 20.11.2026)

Ringkesan rincian data analitis Agape ATP Corp. (ATPC)

- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator dhuwit lan arus kas:
Analisis komprehensif perusahaan:Agape ATP (ATPC)
Produk sing diprodhuksi Agape ATP Corp

Agape ATP Corporation (ATPC) is expanding its wellness business across Asian markets through organic growth and local partnerships without utilizing M&A transactions. By analyzing the current quarterly sales growth on the GURU.Markets platform, an investor assesses the percentage change in revenue between consecutive quarters to identify true demand dynamics. A stable positive trend in this indicator confirms the company's fundamental resilience, eliminating the risk of overpaying for a speculative asset.

Pesaing Agape ATP Corporation (ATPC)

ASND - Wutah pendapatan kuartal marang kuartal|MDGL: Wutah pendapatan kuartal marang kuartal|CORT: Wutah pendapatan triwulanan|RYTM - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Akero Corp|Metsera Therapeutics (MTSR) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal moonlaketx.com (MLTX)|Wutah dodolan triwulanan Crinetics Pharmaceuticals CRNX|Wutah pendapatan kuartal marang kuartal NewAmsterdam Pharma N.V. NAMS|Tingkat wutah dodolan sajrone kuartal Soleno Therapeutics Inc (SLNO)|FOLD - Wutah pendapatan kuartal marang kuartal|ETNB: Wutah pendapatan kuartal marang kuartal|AGIO: Wutah pendapatan triwulanan|Structure Therapeutics Inc. - Tambahing pendapatan triwulanan|MDXG (MiMedx Corp) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Rezolute Inc RZLT|Wutah pendapatan triwulanan LXRX|Tingkat wutah dodolan sajrone kuartal MBX Corp|Altimmune Pharma - Wutah dodolan triwulanan|Wutah pendapatan triwulanan aardvarktherapeutics.com AARD|SGMT: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan BIOA (BioAge Labs)|BMEA: Wutah pendapatan triwulanan|QNCX: Owah-owahan dodolan kuartal marang kuartal|GUTS (Fractyl Health, Inc.) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan vtvtherapeutics.com|Wutah dodolan triwulanan PLUR (Pluri Inc)|Tingkat wutah dodolan sajrone kuartal Synlogic Inc.|Wutah pendapatan kuartal marang kuartal Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Tingkat wutah pendapatan sajrone kuartal|Spruce Biosciences Inc. - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Wutah pendapatan kuartal marang kuartal|Lumos Pharma - Tambahing pendapatan triwulanan|ONVO (Organovo Corp) - Wutah pendapatan triwulanan|Radius Pharmaceuticals (RDUS) - Tingkat wutah dodolan sajrone kuartal